Live News REGULATION FLASH M impact Nov 17, 2026, 05:34 PM UTC FDA Grants Accelerated Approval to Nuvalent's Neladalkib The FDA granted accelerated approval to Nuvalent's neladalkib for ALK-positive NSCLC. GSK SquawkNews Desk